Artemis Medicare Services Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Artemis Medicare Services Ltd is ₹ 286.1 as of 23 Oct 15:30 . The P/E Ratio of Artemis Medicare Services Ltd changed from 45.3 on March 2021 to 31.3 on March 2026 . This represents a CAGR of -5.98% over 6 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Artemis Medicare Services Ltd changed from ₹ 293.88 crore on March 2021 to ₹ 3249 crore on March 2026 . This represents a CAGR of 49.26% over 6 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Artemis Medicare Services Ltd for the Jun '26 is ₹ 292.7 crore as compare to the Mar '26 revenue of ₹ 287.01 crore. This represent the growth of 1.98% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Artemis Medicare Services Ltd for the Jun '26 is ₹ 61.82 crore as compare to the Mar '26 ebitda of ₹ 59.38 crore. This represent the growth of 4.11% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Artemis Medicare Services Ltd changed from ₹ 16.52 crore to ₹ 31.44 crore over 9 quarters. This represents a CAGR of 33.11% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Artemis Medicare Services Ltd changed from 15.2 % on March 2023 to 6.89 % on March 2026 . This represents a CAGR of -17.95% over 4 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Artemis Medicare Services Ltd

Artemis Medicare Services Limited was incorporated on May 18, 2004.
It commenced the commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on July 16, 2007.
The Company is the holding Company of Artemis Cardiac Care Private Limited and a Subsidiary of Constructive Finance Private Limited.
At present, the Company is engaged in managing and operating of multi specialty hospitals.
Artemis Hospital (a unit of Artemis Medicare Services Limited) is spread across 9 acres, is a 395 bed; state-of-the-art multispeciality hospital located in Gurugram, India. Artemis Health Institute is a healthcare venture launched by the Promoters of the Apollo Tyres Group.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Artemis Medicare Services Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Artemis Medicare Services Ltd or Transgene Biotek Ltd?

Market cap of Artemis Medicare Services Ltd is 4,529 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of Artemis Medicare Services Ltd and Transgene Biotek Ltd?

The stock performance of Artemis Medicare Services Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Artemis Medicare Services Ltd and Transgene Biotek Ltd?

As of October 25, 2026, the Artemis Medicare Services Ltd stock price is INR ₹286.1. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of Artemis Medicare Services Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Artemis Medicare Services Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.